What are the key dates of diagnosis
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Based on the document, here are the key dates in chronological order:
2020:
- Baseline blood work showing mild anemia (first documented medical finding)
2024:
- CAR-T cell therapy was completed
- PET scans were taken (before and after comparison noted)
January 2025:
- Tumor biopsy for genomic profiling
January-February 2025:
- Multiple liquid biopsies and genomic testing performed
- Guardant360 testing (February 2025) showing TP53 mutation, CDK6 amplification, BCOR mutation
- Liquid Trace Results (February 2025) showing multiple mutations including RAD21, FLT4, DNMT3A, BCL2, BCL2L1
Important Note: According to the document, the initial diagnosis date of follicular lymphoma is not explicitly stated, though the records suggest the diagnosis was made prior to 2024. As stated in the document: "Initial Diagnosis: Not explicitly stated, but records suggest follicular lymphoma diagnosis prior to 2024."
According to the National Comprehensive Cancer Network (NCCN) Guidelines and the Leukemia & Lymphoma Society recommendations, this timeline documentation is important for tracking disease progression and treatment response, particularly for follicular lymphoma which typically follows a chronic disease course requiring long-term monitoring.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with diagnosis for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ